logo
Sign in

ROTATION MEDICAL INC

PLYMOUTH, MN · Founded 2006 · Biotech · Acquired

Biotherapeutic medicines targeting neurological and systemic diseases

Claim this profile

Follows are private to you and power your alerts

Updated · denalitherapeutics.com

Sector
Biotech
Headquarters
PLYMOUTH, MN
Founded
2006
Latest Form D
$8M, Aug 2016
Total capital
$51.1M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$51.1M
6 Form D · last Aug 2016
123 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
31
9 pending · first 2021
Rank in peer group#18 of 1449

Capital timeline

20092010201120122013201420152016FEDERAL ↑EQUITY ↓Cumulative $51.1M1st Form D$2M3rd Form D$10M5th Form D$21.7M
2009201120132015FEDERAL ↑EQUITY ↓Cumulative $51.1M3rd Form D$10M

Latest events

  • Private capital raisedForm D · SEC · 6th filing$8M
  • Private capital raisedForm D · SEC · 5th filing$21.7M
  • Private capital raisedForm D · SEC · 4th filing$5.5M
  • Private capital raisedForm D · SEC · 3rd filing$10M
  • Private capital raisedForm D · SEC · 2nd filing$3.9M
  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#18 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Charles L. EuteneuerResearcherExecutive OfficerLinked by 5 patents
  • Craig Jay Van KampenResearcherExecutive OfficerLinked by 3 patents
  • Thomas WestlingResearcherExecutive Officer, DirectorLinked by 3 patents
  • Albert Jay GrafDirectorNamed in SEC Form D filings
  • Ali BehbahaniDirectorNamed in SEC Form D filings
  • D. William KaufmanExecutive OfficerNamed in SEC Form D filings
Show all 17 people
  • Fouad AzzamDirectorNamed in SEC Form D filings
  • J. Albert GrafDirectorNamed in SEC Form D filings
  • James R. NessExecutive OfficerNamed in SEC Form D filings
  • Jeff L. SimsExecutive OfficerNamed in SEC Form D filings
  • John William NehraDirectorNamed in SEC Form D filings
  • Kevin SidowDirectorNamed in SEC Form D filings
  • Martha ShadanExecutive Officer, DirectorNamed in SEC Form D filings
  • Michael Jay DeManeDirectorNamed in SEC Form D filings
  • Randy NuernbergExecutive OfficerNamed in SEC Form D filings
  • Scott WeinerDirectorNamed in SEC Form D filings
  • Thomas R. HektnerDirectorNamed in SEC Form D filings

What it has protected

USPTO · 31 granted of 40
Show all 40 patent records

Related companies, and why

  • WHITE ROCK THERAPEUTICSSimilar federal contract value in Biotech · null in contracts
  • Neogene TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • VBI VACCINES INC.Similar federal contract value in Biotech · null in contracts
  • KINETA, INC.Similar federal contract value in Biotech · null in contracts
  • JuvoBio Pharmaceuticals Inc.Similar federal contract value in Biotech · null in contracts
  • ReplimuneSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .